CN116099029A - A kind of disposable postoperative dressing plant concentrated film and its preparation method - Google Patents
A kind of disposable postoperative dressing plant concentrated film and its preparation method Download PDFInfo
- Publication number
- CN116099029A CN116099029A CN202310198017.1A CN202310198017A CN116099029A CN 116099029 A CN116099029 A CN 116099029A CN 202310198017 A CN202310198017 A CN 202310198017A CN 116099029 A CN116099029 A CN 116099029A
- Authority
- CN
- China
- Prior art keywords
- parts
- plant
- dressing plant
- disposable
- concentrated solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/40—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing ingredients of undetermined constitution or reaction products thereof, e.g. plant or animal extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
- A61K31/125—Camphor; Nuclear substituted derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/288—Taraxacum (dandelion)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/744—Gardenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
- A61K38/011—Hydrolysed proteins; Derivatives thereof from plants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/20—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing organic materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/24—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/32—Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/44—Medicaments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/46—Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/216—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials with other specific functional groups, e.g. aldehydes, ketones, phenols, quaternary phosphonium groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/30—Compounds of undetermined constitution extracted from natural sources, e.g. Aloe Vera
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/412—Tissue-regenerating or healing or proliferative agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Materials Engineering (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Dermatology (AREA)
- Zoology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
技术领域technical field
本发明涉及医用敷料技术领域,特别涉及一种一次性术后敷料植物浓缩膜及其制备方法。The invention relates to the technical field of medical dressings, in particular to a disposable postoperative dressing plant concentrated film and a preparation method thereof.
背景技术Background technique
皮肤是防止人体遭受外界环境伤害的第一道防线,能维持正常的体温调节、感受刺激、吸收排泄、免疫调节等生理功能。当皮肤受到外界环境的机械、化学刺激引起的皮肤缺损,不仅会给人带来身体和精神上的伤害,还会给人带来经济上的负担和压力。创伤愈合是一个复杂的过程,经受外伤后,在体内细胞及细胞因子参与并互相作用下,经历凝血、炎症、组织增生、重塑四个动态修复阶段愈合的过程,皮肤受到创伤后,血管破裂,血小板在受损处形成血块填充受损区域,同时血管收缩减少出血量和组织液的渗出,进入炎症阶段,巨噬细胞和中性粒细胞等免疫细胞在信号的介导作用下,会募集在伤口处,将创口处的细胞和组织碎片清除后释放生长因子,刺激并诱导成纤维细胞和内皮细胞的生长和分化,生成新的肉芽组织,新生的肌成纤维细胞拉动皮下组织逐渐向创面进行迁移,生成新的表皮,覆盖创口。现代医学对创伤修复的过程和机制,以及影响伤口修复的细胞因子进行了深入的研究,对于创伤修复有了更清晰的理论基础和更多的治疗方法。The skin is the first line of defense to prevent the human body from being harmed by the external environment. It can maintain normal physiological functions such as temperature regulation, stimulation, absorption and excretion, and immune regulation. When the skin is damaged by mechanical and chemical stimuli from the external environment, it will not only bring physical and mental damage to people, but also bring economic burden and pressure to people. Wound healing is a complex process. After trauma, with the participation and interaction of cells and cytokines in the body, it goes through four dynamic repair stages of blood coagulation, inflammation, tissue proliferation, and remodeling. After the skin is traumatized, blood vessels rupture , platelets form blood clots in the damaged area to fill the damaged area, and at the same time, vasoconstriction reduces the amount of bleeding and the exudation of interstitial fluid, and enters the inflammatory stage. Immune cells such as macrophages and neutrophils will be recruited under the mediation of signals At the wound, growth factors are released after the cells and tissue fragments in the wound are removed, stimulating and inducing the growth and differentiation of fibroblasts and endothelial cells to generate new granulation tissue, and the new myofibroblasts pull the subcutaneous tissue toward the wound gradually Migrate to generate new epidermis to cover the wound. Modern medicine has conducted in-depth research on the process and mechanism of wound repair, as well as the cytokines that affect wound repair, and has a clearer theoretical basis and more treatment methods for wound repair.
目前大多数医用敷料具有覆盖保护、吸水保湿、透气的功效,能满足大多数伤口的治疗需求,然而,伤口的情况不同对敷料的要求也不同,目前市面上许多敷料性能单一、缺乏生物活性和复合治疗功能,难以满足伤口愈合的生理需要,及术后瘢痕严重增生,且未能同时达到创面快速愈合且根治瘢痕的效果。At present, most medical dressings have the functions of covering protection, water absorption, moisturizing, and ventilation, which can meet the treatment needs of most wounds. However, different wound conditions have different requirements for dressings. Many dressings currently on the market have single performance, lack of biological activity and The combined treatment function is difficult to meet the physiological needs of wound healing, and the postoperative scar is severely hypertrophic, and it cannot achieve the effect of rapid wound healing and scar cure at the same time.
发明内容Contents of the invention
鉴于此,本发明提出一种一次性术后敷料植物浓缩膜及其制备方法,解决上述问题。In view of this, the present invention proposes a disposable postoperative dressing plant concentrated film and a preparation method thereof to solve the above problems.
本发明的技术方案是这样实现的:一种一次性术后敷料植物浓缩膜:包括浸提植物浓缩液和辅料,所述浸提植物浓缩液包括以下重量份原料:山银花1-2份、艾叶1-3份、蒲公英1-1.5份、红花0.5-1.5份、山栀子2-3份、芦荟2-3份;所述辅料包括以下重量份原料:樟脑0.5-0.8份、薄荷脑0.5-0.8份、冰片0.5-0.8份、聚乙烯醇0.2-0.3份。The technical solution of the present invention is achieved in the following way: a kind of disposable postoperative dressing plant concentrated film: comprising extracting plant concentrate and auxiliary materials, said extracting plant concentrate comprising the following raw materials in parts by weight: 1-2 parts of Flos Japonica , 1-3 parts of mugwort leaves, 1-1.5 parts of dandelion, 0.5-1.5 parts of safflower, 2-3 parts of gardenia, 2-3 parts of aloe; the auxiliary materials include the following raw materials in parts by weight: 0.5-0.8 parts of camphor, peppermint Brain 0.5-0.8 part, borneol 0.5-0.8 part, polyvinyl alcohol 0.2-0.3 part.
进一步的,所述浸提植物浓缩液包括以下重量份原料:山银花1.8份、艾叶2份、蒲公英1.2份、红花1份、山栀子2.5份、芦荟2.5份。Further, the extracting plant concentrate includes the following raw materials in parts by weight: 1.8 parts of Jasmine japonica, 2 parts of mugwort leaves, 1.2 parts of dandelion, 1 part of safflower, 2.5 parts of gardenia, and 2.5 parts of aloe.
进一步的,所述辅料包括以下重量份原料:樟脑0.75份、薄荷脑0.75份、冰片0.75份、聚乙烯醇0.25份。Further, the auxiliary materials include the following raw materials in parts by weight: 0.75 parts of camphor, 0.75 parts of menthol, 0.75 parts of borneol, and 0.25 parts of polyvinyl alcohol.
进一步的,所述术后敷料植物浓缩膜还包括使料,所述使料包括以下重量份原料:乳木果油0.4-0.9份、白千层油0.6-1.2份、菜籽多肽0.3-0.8份、海藻活性肽0.2-0.4份、p-茴香酸0.03-0.1份,所述海藻活性肽的分子量为5000-1000Da。Further, the postoperative dressing plant concentrated film also includes ingredients, and the ingredients include the following raw materials in parts by weight: 0.4-0.9 parts of shea butter, 0.6-1.2 parts of melaleuca oil, 0.3-0.8 parts of rapeseed polypeptide 0.2-0.4 part of seaweed active peptide, 0.03-0.1 part of p-anisic acid, the molecular weight of the seaweed active peptide is 5000-1000Da.
进一步的,所述辅料、使料和浸提植物浓缩液的质量体积kg/L比为20-30:8-15:100。Further, the mass-to-volume kg/L ratio of the auxiliary material, the preservative, and the extract plant concentrate is 20-30:8-15:100.
进一步的,一种一次性术后敷料植物浓缩膜的制备方法,包括以下步骤:Further, a method for preparing a disposable postoperative dressing plant concentrated film, comprising the following steps:
S1、浸提植物浓缩液:将上述山银花、艾叶、蒲公英、红花、山栀子、芦荟洗净、去杂、晾干、切碎、烘干,烘干后粉碎至100-120目筛成混合粉末,加入去离子水,搅拌均匀,混合粉末和去离子水的质量体积比g/mL为1-3:80,置于超声波提取仪中,在功率为300-500W,温度为60-80℃下提取5-7min,离心分离,取出上清液,得到第一浓缩液,将滤渣再加入去离子水,滤渣和去离子水的质量体积g/mL为1-3:80,重复上述超声提取方法,得到第二浓缩液;S1. Extraction plant concentrate: wash the above-mentioned mountain silver flower, mugwort leaf, dandelion, safflower, gardenia, aloe, remove impurities, dry, chop, dry, and crush to 100-120 mesh after drying Sieve into mixed powder, add deionized water, stir evenly, the mass volume ratio of mixed powder and deionized water g/mL is 1-3:80, put it in an ultrasonic extractor, at a power of 300-500W, a temperature of 60 Extract at -80°C for 5-7 minutes, centrifuge, take out the supernatant to obtain the first concentrated solution, add deionized water to the filter residue, the mass volume g/mL of the filter residue and deionized water is 1-3:80, repeat The above-mentioned ultrasonic extraction method obtains the second concentrated solution;
S2、制备I液:按体积比为6:3-5取上述第一浓缩液和第二浓缩液混合均匀,加入辅料,加热至50-70℃搅拌10-30min,搅拌速率为400-600rpm,得到I液;S2. Preparation of liquid I: Take the above-mentioned first concentrated solution and the second concentrated solution according to the volume ratio of 6:3-5 and mix evenly, add auxiliary materials, heat to 50-70°C and stir for 10-30min, the stirring rate is 400-600rpm, Get liquid I;
S3、制备II液:将使料缓慢加入I液中,边加边搅拌至混合均匀后于40-80℃下高速均质,得到II液。S3. Preparation of liquid II: Slowly add the ingredients into liquid I, stir until evenly mixed, then homogenize at a high speed at 40-80°C to obtain liquid II.
S4、用涂布机将上述I液或II液涂布在无纺布面层上,涂布层厚度为0.1-0.3mm,其后在净放室内常温固化,得到一次性术后敷料植物浓缩膜。S4. Use a coating machine to coat the above-mentioned liquid I or liquid II on the surface layer of the non-woven fabric, the thickness of the coating layer is 0.1-0.3mm, and then solidify it at room temperature in a clean room to obtain a disposable postoperative dressing plant concentrate membrane.
进一步的,所述S3的高速均质条件速率为8000-12000rpm,均质时间10-20min。Further, the high-speed homogenization condition of S3 is 8000-12000rpm, and the homogenization time is 10-20min.
进一步的,一次性术后敷料植物浓缩膜应用于非慢性术后伤口护理。Further, the disposable postoperative dressing plant concentrated film is applied to non-chronic postoperative wound care.
进一步的,非慢性术后伤口护理为外科手术后缝合切口及创面覆盖。Further, non-chronic postoperative wound care is suturing the incision and covering the wound after surgery.
与现有技术相比,本发明的有益效果是:Compared with prior art, the beneficial effect of the present invention is:
本发明的术后敷料植物浓缩膜采用浸提植物浓缩液和辅料及使料协同作用,联合抑菌作用明显增强,刺激性小,无毒副作用,促进伤创面快速愈合,促进恢复皮肤屏障功能,同时避免创面处形成严重的瘢痕;植物浓缩液中各原料按照特定的比例提取有利于提高浓缩膜的修复能力,同时加入使料有助于保持正常的免疫能力,能更好的协助植物浓缩液诱发皮肤系统的免疫和促进细胞增生,加快细胞的修复,放置组织黏连,避免新生皮肤二次损伤,其中乳木果油和白千层油形成稳定的疏水性结构,有利于降低创面处血管的通透性异常,缓解创面处的水肿,菜籽多肽、海藻活性肽可以调控创免除胶原蛋白的合成,有助于创面愈合,浓缩膜析出的有效成分能破坏瘢痕细胞壁,有效成分抑制吸收,去除瘢痕增生细胞和纤维化结缔组织,从而达到根治瘢痕的目的,使瘢痕创面与正常皮肤相当,瘢痕细胞不再继续增生。The post-operative dressing plant concentrated film of the present invention adopts the synergistic effect of extracting plant concentrate, auxiliary materials and materials, and the joint antibacterial effect is significantly enhanced, with little irritation and no toxic side effects, which can promote the rapid healing of wounds and restore the skin barrier function. At the same time, it can avoid the formation of serious scars on the wound surface; extracting the raw materials in the plant concentrate according to a specific ratio is beneficial to improve the repairing ability of the concentrated film, and at the same time adding ingredients can help maintain normal immunity and can better assist the plant concentrate Induce the immunity of the skin system and promote cell proliferation, accelerate cell repair, place tissue adhesion, and avoid secondary damage to the new skin. Among them, shea butter and melaleuca oil form a stable hydrophobic structure, which is beneficial to reduce blood vessels on the wound. The abnormal permeability of the skin can relieve the edema of the wound. Rapeseed polypeptide and seaweed active peptide can regulate the synthesis of collagen in the wound, which is helpful for wound healing. The active ingredients precipitated from the concentrated film can destroy the scar cell wall, and the active ingredients inhibit absorption. Remove scar hyperplasia cells and fibrous connective tissue, so as to achieve the purpose of radical scarring, make scar wounds comparable to normal skin, and scar cells no longer continue to proliferate.
具体实施方式Detailed ways
为了更好理解本发明技术内容,下面提供具体实施例,对本发明做进一步的说明。In order to better understand the technical content of the present invention, specific examples are provided below to further illustrate the present invention.
本发明实施例所用的实验方法如无特殊说明,均为常规方法。The experimental methods used in the examples of the present invention are conventional methods unless otherwise specified.
本发明实施例所用的材料、试剂等,如无特殊说明,均可从商业途径得到。The materials and reagents used in the examples of the present invention can be obtained from commercial sources unless otherwise specified.
实施例1Example 1
一种一次性术后敷料植物浓缩膜:包括浸提植物浓缩液和辅料,所述浸提植物浓缩液每10L包括以下重量原料:山银花1.8kg、艾叶2kg、蒲公英1.2kg、红花1kg、山栀子2.5kg、芦荟2.5kg,余量为去离子水;所述辅料包括以下重量原料:樟脑0.75kg、薄荷脑0.75kg、冰片0.75kg、聚乙烯醇0.25kg;A kind of disposable postoperative dressing plant concentrated film: including extraction plant concentrate and auxiliary materials, said extraction plant concentrate includes the following weight raw materials per 10L: mountain silver flower 1.8kg, Artemisia argyi 2kg, dandelion 1.2kg, safflower 1kg , gardenia 2.5kg, aloe 2.5kg, and the balance is deionized water; the auxiliary materials include the following weight raw materials: camphor 0.75kg, menthol 0.75kg, borneol 0.75kg, polyvinyl alcohol 0.25kg;
上述浓缩膜的制备方法包括以下步骤:The preparation method of above-mentioned concentrated film comprises the following steps:
S1、浸提植物浓缩液:将上述山银花、艾叶、蒲公英、红花、山栀子、芦荟洗净、去杂、晾干、切碎、烘干,烘干后粉碎至120目筛成混合粉末,加入去离子水,搅拌均匀,混合粉末和去离子水的质量体积比g/mL为2:80,置于超声波提取仪中,在功率为400W,温度为70℃下提取6min,离心分离,取出上清液,得到第一浓缩液,将滤渣再加入去离子水,滤渣和去离子水的质量体积g/mL为2:80,重复上述超声提取方法,得到第二浓缩液;S1. Extraction plant concentrate: wash the above-mentioned mountain silver flower, mugwort leaf, dandelion, safflower, gardenia, aloe, remove impurities, dry, chop, dry, and crush to a 120-mesh sieve after drying. Mix the powder, add deionized water, stir evenly, the mass volume ratio of the mixed powder and deionized water g/mL is 2:80, put it in an ultrasonic extractor, extract at a power of 400W and a temperature of 70°C for 6min, and centrifuge Separate, take out the supernatant to obtain the first concentrated solution, add deionized water to the filter residue, the mass volume g/mL of the filter residue and deionized water is 2:80, repeat the above ultrasonic extraction method to obtain the second concentrated solution;
S2、制备I液:取上述第一浓缩液6000mL和第二浓缩液4000mL混合均匀,加入辅料2.5kg,加热至60℃搅拌20min,搅拌速率为500rpm,得到I液;S2. Preparation of liquid I: Take 6000 mL of the above-mentioned first concentrated solution and 4000 mL of the second concentrated liquid and mix evenly, add 2.5 kg of auxiliary materials, heat to 60° C. and stir for 20 minutes at a stirring speed of 500 rpm to obtain liquid I;
S3、用涂布机将上述I液涂布在无纺布面层上,涂布层厚度为0.1-0.3mm,其后在净放室内常温固化,得到一次性术后敷料植物浓缩膜。S3. Use a coating machine to coat the above liquid I on the surface layer of the non-woven fabric, the thickness of the coating layer is 0.1-0.3 mm, and then solidify it at room temperature in a clean room to obtain a disposable postoperative dressing plant concentrated film.
实施例2Example 2
一种一次性术后敷料植物浓缩膜:包括浸提植物浓缩液、辅料和使料,所述浸提植物浓缩液每10L包括以下重量原料:山银花1kg、艾叶1kg、蒲公英1kg、红花0.5kg、山栀子2kg、芦荟2kg;所述辅料包括以下重量原料:樟脑0.5kg、薄荷脑0.5kg、冰片0.5kg、聚乙烯醇0.2kg,所述使料包括以下重量原料:乳木果油0.4kg、白千层油0.6kg、菜籽多肽0.3kg、海藻活性肽0.2kg、p-茴香酸0.03kg,所述海藻活性肽的分子量为5000-1000Da。A disposable postoperative dressing plant concentrated film: including extract plant concentrate, auxiliary materials and materials, the extract plant concentrate contains the following weight raw materials per 10L: 1kg of Yam Flos Japonica, 1kg of Artemisia argyi, 1kg of Dandelion, safflower 0.5kg, gardenia 2kg, aloe 2kg; the auxiliary materials include the following raw materials by weight: camphor 0.5kg, menthol 0.5kg, borneol 0.5kg, polyvinyl alcohol 0.2kg, and the materials include the following raw materials by weight: shea butter Oil 0.4kg, Melaleuca oil 0.6kg, rapeseed polypeptide 0.3kg, seaweed active peptide 0.2kg, p-anisic acid 0.03kg, the molecular weight of the seaweed active peptide is 5000-1000Da.
实施例3Example 3
一种一次性术后敷料植物浓缩膜:包括浸提植物浓缩液、辅料和使料,所述浸提植物浓缩液每10L包括以下重量原料:山银花2kg、艾叶3kg、蒲公英1.5kg、红花1.5kg、山栀子3kg、芦荟3kg;所述辅料包括以下重量原料:樟脑0.8kg、薄荷脑0.8kg、冰片0.8kg、聚乙烯醇0.3kg,所述使料包括以下重量原料:乳木果油0.9kg、白千层油1.2kg、菜籽多肽0.8kg、海藻活性肽0.4kg、p-茴香酸0.1kg,所述海藻活性肽的分子量为5000-1000Da。A kind of one-time postoperative dressing plant concentrated film: including leaching plant concentrate, auxiliary materials and materials, said leaching plant concentrate includes the following weight raw materials per 10L: mountain silver flower 2kg, Artemisia argyi 3kg, dandelion 1.5kg, red Flower 1.5kg, gardenia 3kg, aloe 3kg; the auxiliary materials include the following weight raw materials: camphor 0.8kg, menthol 0.8kg, borneol 0.8kg, polyvinyl alcohol 0.3kg, and the described materials include the following weight raw materials: shea wood 0.9kg of fruit oil, 1.2kg of melaleuca oil, 0.8kg of rapeseed polypeptide, 0.4kg of seaweed active peptide, and 0.1kg of p-anisic acid. The molecular weight of the seaweed active peptide is 5000-1000Da.
实施例4Example 4
一种一次性术后敷料植物浓缩膜:包括浸提植物浓缩液、辅料和使料,所述浸提植物浓缩液每10升包括以下重量原料:山银花1.8kg、艾叶2kg、蒲公英1.2kg、红花1kg、山栀子2.5kg、芦荟2.5kg,所述辅料包括以下重量原料:樟脑0.75kg、薄荷脑0.75kg、冰片0.75kg、聚乙烯醇0.25kg,所述使料包括以下重量原料:乳木果油0.6kg、白千层油0.9kg、菜籽多肽0.5kg、海藻活性肽0.3kg、p-茴香酸0.06kg,所述海藻活性肽的分子量为5000-1000Da;A kind of one-time postoperative dressing plant concentrated film: including leaching plant concentrate, auxiliary materials and materials, said leaching plant concentrate includes the following weight raw materials per 10 liters: 1.8kg of mountain silver flower, 2kg of Artemisia argyi, 1.2kg of dandelion , safflower 1kg, jasmine jasmine 2.5kg, aloe 2.5kg, described auxiliary material comprises following weight raw material: camphor 0.75kg, menthol 0.75kg, borneol 0.75kg, polyvinyl alcohol 0.25kg, described making material comprises following weight raw material : Shea butter 0.6kg, melaleuca oil 0.9kg, rapeseed polypeptide 0.5kg, seaweed active peptide 0.3kg, p-anisic acid 0.06kg, the molecular weight of the seaweed active peptide is 5000-1000Da;
上述实施例2-4采用以下制备方法:Above-mentioned embodiment 2-4 adopts following preparation method:
S1、浸提植物浓缩液:将上述山银花、艾叶、蒲公英、红花、山栀子、芦荟洗净、去杂、晾干、切碎、烘干,烘干后粉碎至110目筛成混合粉末,加入去离子水,搅拌均匀,混合粉末和去离子水的质量体积比g/mL为2:80,置于超声波提取仪中,在功率为400W,温度为70℃下提取6min,离心分离,取出上清液,得到第一浓缩液,将滤渣再加入去离子水,滤渣和去离子水的质量体积g/mL为2:80,重复上述超声提取方法,得到第二浓缩液;S1. Extraction plant concentrate: wash the above-mentioned mountain silver flower, mugwort leaves, dandelion, safflower, gardenia, aloe, remove impurities, dry, chop, dry, and crush to a 110-mesh sieve after drying. Mix the powder, add deionized water, stir evenly, the mass volume ratio of the mixed powder and deionized water g/mL is 2:80, put it in an ultrasonic extractor, extract at a power of 400W and a temperature of 70°C for 6min, and centrifuge Separate, take out the supernatant to obtain the first concentrated solution, add deionized water to the filter residue, the mass volume g/mL of the filter residue and deionized water is 2:80, repeat the above ultrasonic extraction method to obtain the second concentrated solution;
S2、制备I液:按体积比为6:4取上述第一浓缩液和第二浓缩液混合均匀,加入辅料,加热至60℃搅拌20min,搅拌速率为500rpm,得到I液;S2. Preparation of liquid I: Take the above-mentioned first concentrated liquid and the second concentrated liquid at a volume ratio of 6:4 and mix evenly, add auxiliary materials, heat to 60° C. and stir for 20 minutes at a stirring speed of 500 rpm to obtain liquid I;
S3、制备II液:将使料缓慢加入I液中,边加边搅拌至混合均匀后于60℃下高速均质,高速均质条件速率为10000rpm,均质时间15min,得到II液。S3. Preparation of liquid II: Slowly add the ingredients into liquid I, stir until evenly mixed, then homogenize at a high speed at 60°C, the speed of high-speed homogenization is 10,000 rpm, and the homogenization time is 15 minutes, to obtain liquid II.
S4、用涂布机将上述II液涂布在无纺布面层上,涂布层厚度为0.2mm,其后在净放室内常温固化,得到一次性术后敷料植物浓缩膜。S4. Use a coating machine to coat the above-mentioned liquid II on the surface layer of the non-woven fabric, the thickness of the coating layer is 0.2 mm, and then solidify it in a clean room at room temperature to obtain a disposable postoperative dressing plant concentrated film.
实施例5Example 5
一种一次性术后敷料植物浓缩膜:包括浸提植物浓缩液、辅料和使料,所述浸提植物浓缩液每10升包括以下重量原料:山银花1.8kg、艾叶2kg、蒲公英1.2kg、红花1kg、山栀子2.5kg、芦荟2.5kg,所述辅料包括以下重量原料:樟脑0.75kg、薄荷脑0.75kg、冰片0.75kg、聚乙烯醇0.25kg,所述使料包括以下重量原料:乳木果油0.6kg、白千层油0.9kg、菜籽多肽0.5kg、海藻活性肽0.3kg、p-茴香酸0.06kg,所述海藻活性肽的分子量为5000-1000Da;A kind of one-time postoperative dressing plant concentrated film: including leaching plant concentrate, auxiliary materials and materials, said leaching plant concentrate includes the following weight raw materials per 10 liters: 1.8kg of mountain silver flower, 2kg of Artemisia argyi, 1.2kg of dandelion , safflower 1kg, jasmine jasmine 2.5kg, aloe 2.5kg, described auxiliary material comprises following weight raw material: camphor 0.75kg, menthol 0.75kg, borneol 0.75kg, polyvinyl alcohol 0.25kg, described making material comprises following weight raw material : Shea butter 0.6kg, melaleuca oil 0.9kg, rapeseed polypeptide 0.5kg, seaweed active peptide 0.3kg, p-anisic acid 0.06kg, the molecular weight of the seaweed active peptide is 5000-1000Da;
上述浓缩膜采用以下制备方法:Above-mentioned concentrated film adopts following preparation method:
S1、浸提植物浓缩液:将上述山银花、艾叶、蒲公英、红花、山栀子、芦荟洗净、去杂、晾干、切碎、烘干,烘干后粉碎至100目筛成混合粉末,加入去离子水,搅拌均匀,混合粉末和去离子水的质量体积比g/mL为1:80,置于超声波提取仪中,在功率为300W,温度为60℃下提取5min,离心分离,取出上清液,得到第一浓缩液,将滤渣再加入去离子水,滤渣和去离子水的质量体积g/mL为1:80,重复上述超声提取方法,得到第二浓缩液;S1. Extraction plant concentrate: wash the above-mentioned mountain silver flower, mugwort leaf, dandelion, safflower, gardenia, aloe, remove impurities, dry, chop, dry, and crush to 100 mesh sieve after drying. Mix the powder, add deionized water, stir evenly, the mass volume ratio of the mixed powder and deionized water g/mL is 1:80, put it in an ultrasonic extractor, extract at a power of 300W and a temperature of 60°C for 5min, and centrifuge Separating, taking out the supernatant to obtain the first concentrated solution, adding deionized water to the filter residue, the mass volume g/mL of the filter residue and deionized water is 1:80, repeating the above ultrasonic extraction method to obtain the second concentrated solution;
S2、制备I液:按体积比为6:3取上述第一浓缩液和第二浓缩液混合均匀,加入辅料,加热至50-70℃搅拌10min,搅拌速率为400rpm,得到I液;S2. Preparation of liquid I: Take the above-mentioned first concentrated liquid and the second concentrated liquid at a volume ratio of 6:3 and mix evenly, add auxiliary materials, heat to 50-70° C. and stir for 10 min at a stirring speed of 400 rpm to obtain liquid I;
S3、制备II液:将使料缓慢加入I液中,边加边搅拌至混合均匀后于40℃下高速均质,高速均质条件速率为8000rpm,均质时间10min,得到II液。S3. Preparation of liquid II: Slowly add the ingredients into liquid I, stir while adding until evenly mixed, then homogenize at a high speed at 40°C, the speed of high-speed homogenization is 8000rpm, and the homogenization time is 10min, to obtain liquid II.
S4、用涂布机将上述I液或II液涂布在无纺布面层上,涂布层厚度为0.1-0.3mm,其后在净放室内常温固化,得到一次性术后敷料植物浓缩膜。S4. Use a coating machine to coat the above-mentioned liquid I or liquid II on the surface layer of the non-woven fabric, the thickness of the coating layer is 0.1-0.3mm, and then solidify it at room temperature in a clean room to obtain a disposable postoperative dressing plant concentrate membrane.
实施例6Example 6
一种一次性术后敷料植物浓缩膜:包括浸提植物浓缩液、辅料和使料,所述浸提植物浓缩液每10升包括以下重量原料:山银花1.8kg、艾叶2kg、蒲公英1.2kg、红花1kg、山栀子2.5kg、芦荟2.5kg,所述辅料包括以下重量原料:樟脑0.75kg、薄荷脑0.75kg、冰片0.75kg、聚乙烯醇0.25kg,所述使料包括以下重量原料:乳木果油0.6kg、白千层油0.9kg、菜籽多肽0.5kg、海藻活性肽0.3kg、p-茴香酸0.06kg,所述海藻活性肽的分子量为5000-1000Da;A kind of one-time postoperative dressing plant concentrated film: including leaching plant concentrate, auxiliary materials and materials, said leaching plant concentrate includes the following weight raw materials per 10 liters: 1.8kg of mountain silver flower, 2kg of Artemisia argyi, 1.2kg of dandelion , safflower 1kg, jasmine jasmine 2.5kg, aloe 2.5kg, described auxiliary material comprises following weight raw material: camphor 0.75kg, menthol 0.75kg, borneol 0.75kg, polyvinyl alcohol 0.25kg, described making material comprises following weight raw material : Shea butter 0.6kg, melaleuca oil 0.9kg, rapeseed polypeptide 0.5kg, seaweed active peptide 0.3kg, p-anisic acid 0.06kg, the molecular weight of the seaweed active peptide is 5000-1000Da;
上述浓缩膜采用以下制备方法:Above-mentioned concentrated film adopts following preparation method:
S1、浸提植物浓缩液:将上述山银花、艾叶、蒲公英、红花、山栀子、芦荟洗净、去杂、晾干、切碎、烘干,烘干后粉碎至120目筛成混合粉末,加入去离子水,搅拌均匀,混合粉末和去离子水的质量体积比g/mL为3:80,置于超声波提取仪中,在功率为500W,温度为80℃下提取7min,离心分离,取出上清液,得到第一浓缩液,将滤渣再加入去离子水,滤渣和去离子水的质量体积g/mL为3:80,重复上述超声提取方法,得到第二浓缩液;S1. Extraction plant concentrate: wash the above-mentioned mountain silver flower, mugwort leaf, dandelion, safflower, gardenia, aloe, remove impurities, dry, chop, dry, and crush to a 120-mesh sieve after drying. Mix the powder, add deionized water, stir evenly, the mass volume ratio of the mixed powder and deionized water g/mL is 3:80, place in an ultrasonic extractor, extract at a power of 500W and a temperature of 80°C for 7min, centrifuge Separate, take out the supernatant to obtain the first concentrated solution, add deionized water to the filter residue, the mass volume g/mL of the filter residue and deionized water is 3:80, repeat the above ultrasonic extraction method to obtain the second concentrated solution;
S2、制备I液:按体积比为6:5取上述第一浓缩液和第二浓缩液混合均匀,加入辅料,加热至70℃搅拌30min,搅拌速率为600rpm,得到I液;S2. Preparation of liquid I: Take the above-mentioned first concentrated liquid and the second concentrated liquid at a volume ratio of 6:5 and mix evenly, add auxiliary materials, heat to 70° C. and stir for 30 minutes at a stirring rate of 600 rpm to obtain liquid I;
S3、制备II液:将使料缓慢加入I液中,边加边搅拌至混合均匀后于80℃下高速均质,高速均质条件速率为12000rpm,均质时间20min,得到II液。S3. Preparation of liquid II: Slowly add the ingredients into liquid I, stir while adding until evenly mixed, then homogenize at a high speed at 80°C, the speed of high-speed homogenization is 12000 rpm, and the homogenization time is 20 minutes, to obtain liquid II.
S4、用涂布机将上述I液或II液涂布在无纺布面层上,涂布层厚度为0.1-0.3mm,其后在净放室内常温固化,得到一次性术后敷料植物浓缩膜。S4. Use a coating machine to coat the above-mentioned liquid I or liquid II on the surface layer of the non-woven fabric, the thickness of the coating layer is 0.1-0.3mm, and then solidify it at room temperature in a clean room to obtain a disposable postoperative dressing plant concentrate membrane.
对比例1Comparative example 1
本对比例与实施例1的区别在于,所述浸提植物浓缩液每10L包括以下重量原料:山银花3kg、艾叶1kg、蒲公英2kg、红花0.1kg、山栀子1kg、芦荟5kg。The difference between this comparative example and Example 1 is that each 10L of the extracted plant concentrate includes the following weight raw materials: 3 kg of Lily japonicus, 1 kg of Artemisia argyi, 2 kg of dandelion, 0.1 kg of safflower, 1 kg of Jasmine jasminoides, and 5 kg of aloe.
具体为一种一次性术后敷料植物浓缩膜:包括浸提植物浓缩液和辅料,所述浸提植物浓缩液每10L包括以下重量原料:山银花3kg、艾叶1kg、蒲公英2kg、红花0.1kg、山栀子1kg、芦荟5kg,余量为去离子水;所述辅料包括以下重量原料:樟脑0.75kg、薄荷脑0.75kg、冰片0.75kg、聚乙烯醇0.25kg;Specifically, it is a kind of one-time postoperative dressing plant concentrated film: including extract plant concentrate and auxiliary materials, the extract plant concentrate contains the following weight raw materials per 10L: mountain silver flower 3kg, mugwort leaf 1kg, dandelion 2kg, safflower 0.1 kg, gardenia jasmine 1kg, aloe 5kg, and the balance is deionized water; the auxiliary materials include the following raw materials by weight: 0.75kg camphor, 0.75kg menthol, 0.75kg borneol, 0.25kg polyvinyl alcohol;
上述浓缩膜的制备方法包括以下步骤:The preparation method of above-mentioned concentrated film comprises the following steps:
S1、浸提植物浓缩液:将上述山银花、艾叶、蒲公英、红花、山栀子、芦荟洗净、去杂、晾干、切碎、烘干,烘干后粉碎至120目筛成混合粉末,加入去离子水,搅拌均匀,混合粉末和去离子水的质量体积比g/mL为2:80,置于超声波提取仪中,在功率为400W,温度为70℃下提取6min,离心分离,取出上清液,得到第一浓缩液,将滤渣再加入去离子水,滤渣和去离子水的质量体积g/mL为2:80,重复上述超声提取方法,得到第二浓缩液;S1. Extraction plant concentrate: wash the above-mentioned mountain silver flower, mugwort leaf, dandelion, safflower, gardenia, aloe, remove impurities, dry, chop, dry, and crush to a 120-mesh sieve after drying. Mix the powder, add deionized water, stir evenly, the mass volume ratio of the mixed powder and deionized water g/mL is 2:80, put it in an ultrasonic extractor, extract at a power of 400W and a temperature of 70°C for 6min, and centrifuge Separate, take out the supernatant to obtain the first concentrated solution, add deionized water to the filter residue, the mass volume g/mL of the filter residue and deionized water is 2:80, repeat the above ultrasonic extraction method to obtain the second concentrated solution;
S2、制备I液:取上述第一浓缩液6000mL和第二浓缩液4000mL混合均匀,加入辅料2.5kg,加热至60℃搅拌20min,搅拌速率为500rpm,得到I液;S2. Preparation of liquid I: Take 6000 mL of the above-mentioned first concentrated solution and 4000 mL of the second concentrated liquid and mix evenly, add 2.5 kg of auxiliary materials, heat to 60° C. and stir for 20 minutes at a stirring speed of 500 rpm to obtain liquid I;
S3、用涂布机将上述I液涂布在无纺布面层上,涂布层厚度为0.1-0.3mm,其后在净放室内常温固化,得到一次性术后敷料植物浓缩膜。S3. Use a coating machine to coat the above liquid I on the surface layer of the non-woven fabric, the thickness of the coating layer is 0.1-0.3 mm, and then solidify it at room temperature in a clean room to obtain a disposable postoperative dressing plant concentrated film.
对比例2Comparative example 2
本对比例与实施例4的区别在于,所述使料包括以下重量原料:乳木果油0.1kg、白千层油0.2kg、菜籽多肽0.1kg、海藻活性肽0.5kg、p-茴香酸0.01kg;The difference between this comparative example and Example 4 is that the ingredients include the following raw materials by weight: 0.1kg of shea butter, 0.2kg of melaleuca oil, 0.1kg of rapeseed polypeptide, 0.5kg of seaweed active peptide, p-anisic acid 0.01kg;
具体为一种一次性术后敷料植物浓缩膜:包括浸提植物浓缩液、辅料和使料,所述浸提植物浓缩液每10升包括以下重量原料:山银花1.8kg、艾叶2kg、蒲公英1.2kg、红花1kg、山栀子2.5kg、芦荟2.5kg,所述辅料包括以下重量原料:樟脑0.75kg、薄荷脑0.75kg、冰片0.75kg、聚乙烯醇0.25kg,所述使料包括以下重量原料:乳木果油0.1kg、白千层油0.2kg、菜籽多肽0.1kg、海藻活性肽0.5kg、p-茴香酸0.01kg,所述海藻活性肽的分子量为5000-1000Da;Specifically, it is a kind of one-time postoperative dressing plant concentrated film: including extract plant concentrate, auxiliary materials and materials, and the extract plant concentrate contains the following weight raw materials per 10 liters: 1.8kg of mountain silver flower, 2kg of Artemisia argyi, dandelion 1.2kg, safflower 1kg, gardenia jasmine 2.5kg, aloe 2.5kg, described auxiliary material comprises following weight raw material: camphor 0.75kg, menthol 0.75kg, borneol 0.75kg, polyvinyl alcohol 0.25kg, described auxiliary material comprises following Weight raw materials: 0.1kg of shea butter, 0.2kg of melaleuca oil, 0.1kg of rapeseed polypeptide, 0.5kg of seaweed active peptide, 0.01kg of p-anisic acid, the molecular weight of the seaweed active peptide is 5000-1000Da;
上述浓缩膜采用以下制备方法:Above-mentioned concentrated film adopts following preparation method:
S1、浸提植物浓缩液:将上述山银花、艾叶、蒲公英、红花、山栀子、芦荟洗净、去杂、晾干、切碎、烘干,烘干后粉碎至110目筛成混合粉末,加入去离子水,搅拌均匀,混合粉末和去离子水的质量体积比g/mL为2:80,置于超声波提取仪中,在功率为400W,温度为70℃下提取6min,离心分离,取出上清液,得到第一浓缩液,将滤渣再加入去离子水,滤渣和去离子水的质量体积g/mL为2:80,重复上述超声提取方法,得到第二浓缩液;S1. Extraction plant concentrate: wash the above-mentioned mountain silver flower, mugwort leaves, dandelion, safflower, gardenia, aloe, remove impurities, dry, chop, dry, and crush to a 110-mesh sieve after drying. Mix the powder, add deionized water, stir evenly, the mass volume ratio of the mixed powder and deionized water g/mL is 2:80, put it in an ultrasonic extractor, extract at a power of 400W and a temperature of 70°C for 6min, and centrifuge Separate, take out the supernatant to obtain the first concentrated solution, add deionized water to the filter residue, the mass volume g/mL of the filter residue and deionized water is 2:80, repeat the above ultrasonic extraction method to obtain the second concentrated solution;
S2、制备I液:按体积比为6:4取上述第一浓缩液和第二浓缩液混合均匀,加入辅料,加热至60℃搅拌20min,搅拌速率为500rpm,得到I液;S2. Preparation of liquid I: Take the above-mentioned first concentrated liquid and the second concentrated liquid at a volume ratio of 6:4 and mix evenly, add auxiliary materials, heat to 60° C. and stir for 20 minutes at a stirring speed of 500 rpm to obtain liquid I;
S3、制备II液:将使料缓慢加入I液中,边加边搅拌至混合均匀后于60℃下高速均质,高速均质条件速率为10000rpm,均质时间15min,得到II液。S3. Preparation of liquid II: Slowly add the ingredients into liquid I, stir until evenly mixed, then homogenize at a high speed at 60°C, the speed of high-speed homogenization is 10,000 rpm, and the homogenization time is 15 minutes, to obtain liquid II.
S4、用涂布机将上述II液涂布在无纺布面层上,涂布层厚度为0.2mm,其后在净放室内常温固化,得到一次性术后敷料植物浓缩膜。S4. Use a coating machine to coat the above-mentioned liquid II on the surface layer of the non-woven fabric, the thickness of the coating layer is 0.2 mm, and then solidify it in a clean room at room temperature to obtain a disposable postoperative dressing plant concentrated film.
对比例3Comparative example 3
本对比例与实施例4的区别在于,所述使料中将乳木果油和白千层油替换成等量的棕榈油和菜籽油。The difference between this comparative example and Example 4 is that the shea butter and the melaleuca oil are replaced by equal amounts of palm oil and rapeseed oil in the described materials.
具体为一种一次性术后敷料植物浓缩膜:包括浸提植物浓缩液、辅料和使料,所述浸提植物浓缩液每10升包括以下重量原料:山银花1.8kg、艾叶2kg、蒲公英1.2kg、红花1kg、山栀子2.5kg、芦荟2.5kg,所述辅料包括以下重量原料:樟脑0.75kg、薄荷脑0.75kg、冰片0.75kg、聚乙烯醇0.25kg,所述使料包括以下重量原料:棕榈油0.6kg、菜籽油0.9kg、菜籽多肽0.5kg、海藻活性肽0.3kg、p-茴香酸0.06kg,所述海藻活性肽的分子量为5000-1000Da;Specifically, it is a kind of one-time postoperative dressing plant concentrated film: including extract plant concentrate, auxiliary materials and materials, and the extract plant concentrate contains the following weight raw materials per 10 liters: 1.8kg of mountain silver flower, 2kg of Artemisia argyi, dandelion 1.2kg, safflower 1kg, gardenia jasmine 2.5kg, aloe 2.5kg, described auxiliary material comprises following weight raw material: camphor 0.75kg, menthol 0.75kg, borneol 0.75kg, polyvinyl alcohol 0.25kg, described auxiliary material comprises following Weight raw materials: palm oil 0.6kg, rapeseed oil 0.9kg, rapeseed polypeptide 0.5kg, seaweed active peptide 0.3kg, p-anisic acid 0.06kg, the molecular weight of the seaweed active peptide is 5000-1000Da;
上述浓缩膜采用以下制备方法:Above-mentioned concentrated film adopts following preparation method:
S1、浸提植物浓缩液:将上述山银花、艾叶、蒲公英、红花、山栀子、芦荟洗净、去杂、晾干、切碎、烘干,烘干后粉碎至110目筛成混合粉末,加入去离子水,搅拌均匀,混合粉末和去离子水的质量体积比g/mL为2:80,置于超声波提取仪中,在功率为400W,温度为70℃下提取6min,离心分离,取出上清液,得到第一浓缩液,将滤渣再加入去离子水,滤渣和去离子水的质量体积g/mL为2:80,重复上述超声提取方法,得到第二浓缩液;S1. Extraction plant concentrate: wash the above-mentioned mountain silver flower, mugwort leaves, dandelion, safflower, gardenia, aloe, remove impurities, dry, chop, dry, and crush to a 110-mesh sieve after drying. Mix the powder, add deionized water, stir evenly, the mass volume ratio of the mixed powder and deionized water g/mL is 2:80, put it in an ultrasonic extractor, extract at a power of 400W and a temperature of 70°C for 6min, and centrifuge Separate, take out the supernatant to obtain the first concentrated solution, add deionized water to the filter residue, the mass volume g/mL of the filter residue and deionized water is 2:80, repeat the above ultrasonic extraction method to obtain the second concentrated solution;
S2、制备I液:按体积比为6:4取上述第一浓缩液和第二浓缩液混合均匀,加入辅料,加热至60℃搅拌20min,搅拌速率为500rpm,得到I液;S2. Preparation of liquid I: Take the above-mentioned first concentrated liquid and the second concentrated liquid at a volume ratio of 6:4 and mix evenly, add auxiliary materials, heat to 60° C. and stir for 20 minutes at a stirring speed of 500 rpm to obtain liquid I;
S3、制备II液:将使料缓慢加入I液中,边加边搅拌至混合均匀后于60℃下高速均质,高速均质条件速率为10000rpm,均质时间15min,得到II液。S3. Preparation of liquid II: Slowly add the ingredients into liquid I, stir until evenly mixed, then homogenize at a high speed at 60°C, the speed of high-speed homogenization is 10,000 rpm, and the homogenization time is 15 minutes, to obtain liquid II.
S4、用涂布机将上述II液涂布在无纺布面层上,涂布层厚度为0.2mm,其后在净放室内常温固化,得到一次性术后敷料植物浓缩膜。S4. Use a coating machine to coat the above-mentioned liquid II on the surface layer of the non-woven fabric, the thickness of the coating layer is 0.2 mm, and then solidify it in a clean room at room temperature to obtain a disposable postoperative dressing plant concentrated film.
对比例4Comparative example 4
本对比例与实施例4的区别在于,所述使料中不含有菜籽多肽。The difference between this comparative example and Example 4 is that the said feed does not contain rapeseed polypeptide.
对比例5Comparative example 5
本对比例与实施例4的区别在于,所述使料中不含有海藻活性肽。The difference between this comparative example and Example 4 is that the active ingredient does not contain seaweed peptides.
一、安全性实验1. Safety experiment
将实施例1-6和对比例1-5的一次性术后敷料植物浓缩膜分别进行动物皮肤刺激试验、皮肤致敏试验、体外细胞毒性试验,结果表明安全无毒。The disposable postoperative dressing plant concentrate films of Examples 1-6 and Comparative Examples 1-5 were respectively subjected to animal skin irritation test, skin sensitization test, and in vitro cytotoxicity test, and the results showed that they were safe and non-toxic.
二、抑菌性能测试2. Antibacterial performance test
根据2020版《中国药典》:抑菌效力检查法要点测试实施例1的I液和实施例2-6的II液对金黄色葡萄球菌、大肠杆菌、化脓性链球菌、铜绿假单胞菌的抑菌效果,结果如下表1:According to the 2020 version of "Chinese Pharmacopoeia": Antibacterial Effectiveness Inspection Method I liquid of embodiment 1 and II liquid of embodiment 2-6 are to Staphylococcus aureus, Escherichia coli, Streptococcus pyogenes, Pseudomonas aeruginosa Bacteriostasis effect, the results are as follows in Table 1:
从上表可知,本发明的制备的敷料植物浓缩膜对金黄色葡萄球菌、大肠杆菌、化脓性链球菌、铜绿假单胞菌的抑菌性在95%以上,其中实施例4的抑菌效果更佳。As can be seen from the above table, the dressing plant concentrated film prepared by the present invention is more than 95% bacteriostatic to Staphylococcus aureus, Escherichia coli, Streptococcus pyogenes, Pseudomonas aeruginosa, wherein the bacteriostatic effect of Example 4 better.
三、创面修复实验3. Wound repair experiment
1、实验动物及分组:选取SD大鼠60只,雌雄各半,随机分为6组,分别对应实施例4和对比例1-5,每组10只。1. Experimental animals and grouping: Select 60 SD rats, half male and half male, and randomly divide them into 6 groups, corresponding to Example 4 and Comparative Examples 1-5 respectively, with 10 rats in each group.
2、实验方法:大鼠用4%水合氯醛麻醉后,脱去大鼠背部的毛,脱毛面积为5×4cm,以切伤、裂伤、擦伤、烧烫伤、缝合伤口等创面积<20cm2的皮肤浅表II级损伤,分别于创面部位贴覆本发明的敷料植物浓缩膜,每天给药2次,早晚各一次,分别统计愈合时间和7天平均愈合率,2. Experimental method: After the rat was anesthetized with 4% chloral hydrate, the hair on the back of the rat was removed. The depilated area was 5×4cm. 20cm skin superficial II level damage, respectively sticking dressing plant concentrated film of the present invention on the wound site, administration 2 times a day, once in the morning and evening, counting the healing time and 7-day average healing rate respectively,
愈合率%=愈合面积/创伤面积×100Healing rate% = healing area/wound area × 100
结果如下表2:The results are shown in Table 2 below:
由表2可以看出实施例4中大鼠创面愈合速度高于对比例1-5,且愈合率均高于对比例1-5,本发明制得的敷料植物浓缩膜明显缩短了创面愈合时间,创面伤口修复效果好,降低了创面渗出液的分泌,促进皮肤组织的重建,加速受损细胞的修复,与对比例1比较,植物浓缩液中各原料按照特定的比例提取有利于提高浓缩膜的修复能力,同时加入使料有助于保持正常的免疫能力,植物浓缩液和辅料、使料协同作用促进伤创面快速愈合,促进恢复皮肤屏障功能;As can be seen from Table 2, the wound healing rate of rats in Example 4 is higher than that of Comparative Examples 1-5, and the healing rate is higher than that of Comparative Examples 1-5, and the dressing plant concentrated film prepared by the present invention obviously shortens the wound healing time , the wound repair effect is good, it reduces the secretion of wound exudate, promotes the reconstruction of skin tissue, and accelerates the repair of damaged cells. The repairing ability of the membrane, while adding ingredients can help maintain normal immunity. The plant concentrate, accessories, and ingredients work together to promote the rapid healing of wounds and promote the restoration of skin barrier function;
与对比例2比较,使料经科学配比筛选出合理的原料能更好的协助植物浓缩液诱发皮肤系统的免疫和促进细胞增生,加快细胞的修复,放置组织黏连,避免新生皮肤二次损伤;Compared with Comparative Example 2, the reasonable raw materials screened by the scientific ratio can better assist the plant concentrate to induce the immunity of the skin system and promote cell proliferation, accelerate the repair of cells, prevent tissue adhesion, and avoid secondary skin regeneration. damage;
与对比例3比较,乳木果油和白千层油形成稳定的疏水性结构,有利于降低创面处血管的通透性异常,缓解创面处的水肿,Compared with Comparative Example 3, shea butter and melaleuca oil form a stable hydrophobic structure, which is beneficial to reduce the abnormal permeability of blood vessels in the wound and relieve the edema of the wound.
与对比例4、5比较,使用菜籽多肽、海藻活性肽可以调控创免除胶原蛋白的合成,有助于创面愈合。Compared with Comparative Examples 4 and 5, the use of rapeseed polypeptide and seaweed active peptide can regulate the synthesis of wound collagen and help wound healing.
四、除疤性能测试4. Scar removal performance test
选用经外科手术后缝合切口有增生性瘢痕的患者40例,其中男性22例,女性18例,年龄10-50岁,随机分为2组,每组20人,一组实验组为实施例4的II液,一组对照组为市售丝芙康敷料,每天贴敷5h,治疗30天。Select 40 patients with hypertrophic scars in the sutured incision after surgical operation, including 22 males and 18 females, aged 10-50 years old, randomly divided into 2 groups, 20 people in each group, one group of experimental group is embodiment 4 The II solution of the drug, and a group of control groups were commercially available Sefcon dressings, which were applied for 5 hours a day and treated for 30 days.
疗效标准:Curative effect standard:
疗效结果如下表3:The curative effect results are as follows in Table 3:
从表3可以看出,与市售比较,本发明的术后敷料植物浓缩膜对外科手术后缝合切口创面具有较好的愈合效果,同时避免创面处形成严重的瘢痕,创面瘢痕处无瘙痒、灼热、疼痛,瘢痕充血减退,颜色逐渐与肤色相同,瘢痕表面毛细血管消失,瘢痕变软、厚度降低至与正常皮肤相当,瘢痕细胞不再继续增生。As can be seen from Table 3, compared with the commercially available, the postoperative dressing plant concentrated film of the present invention has a better healing effect on the sutured incision wound after the surgical operation, while avoiding the formation of serious scars at the wounds, and the scars of the wounds without itching, Burning heat, pain, scar hyperemia subsided, the color gradually became the same as the skin color, the capillaries on the scar surface disappeared, the scar became soft, the thickness was reduced to be equivalent to that of normal skin, and the scar cells no longer continued to proliferate.
以上所述仅为本发明的较佳实施例而已,并不用以限制本发明,凡在本发明的精神和原则之内,所作的任何修改、等同替换、改进等,均应包含在本发明的保护范围之内。The above descriptions are only preferred embodiments of the present invention, and are not intended to limit the present invention. Any modifications, equivalent replacements, improvements, etc. made within the spirit and principles of the present invention shall be included in the scope of the present invention. within the scope of protection.
Claims (9)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202310198017.1A CN116099029B (en) | 2023-03-03 | 2023-03-03 | A disposable postoperative dressing plant concentrated film and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202310198017.1A CN116099029B (en) | 2023-03-03 | 2023-03-03 | A disposable postoperative dressing plant concentrated film and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN116099029A true CN116099029A (en) | 2023-05-12 |
| CN116099029B CN116099029B (en) | 2025-05-16 |
Family
ID=86265562
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202310198017.1A Active CN116099029B (en) | 2023-03-03 | 2023-03-03 | A disposable postoperative dressing plant concentrated film and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN116099029B (en) |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1335184A (en) * | 2000-07-20 | 2002-02-13 | 海南新阳光药业有限公司 | Disposable adhesive dressing and its production process |
| US20120308637A1 (en) * | 2009-11-03 | 2012-12-06 | Guy Chamberland | Compositions comprising extracts of boswellia, tea tree, aloe and lavender oil and methods of treating wounds, burns and skin injuries therewith |
| US20120328721A1 (en) * | 2009-11-16 | 2012-12-27 | L | Aloe vera sprout concentrate or extract having superior skin cell growth promotion, antioxidant, and anti-allergy effects |
| CN106421511A (en) * | 2016-12-28 | 2017-02-22 | 四川默森药业有限公司 | Aloe antibacterial composition and preparation method thereof |
| CN107007794A (en) * | 2017-06-04 | 2017-08-04 | 重庆华邦医美科技有限公司 | It is a kind of to treat Chinese herbal ointment of scar and preparation method thereof |
| US20180085486A1 (en) * | 2015-05-29 | 2018-03-29 | Shirley X. CHEN | Multifunctional composite skin or wound dressing as regenerative skin substitute |
| CN112618646A (en) * | 2020-12-30 | 2021-04-09 | 王水龙 | Traditional Chinese medicine composition and traditional Chinese medicine oil for treating burns and preparation method thereof |
-
2023
- 2023-03-03 CN CN202310198017.1A patent/CN116099029B/en active Active
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1335184A (en) * | 2000-07-20 | 2002-02-13 | 海南新阳光药业有限公司 | Disposable adhesive dressing and its production process |
| US20120308637A1 (en) * | 2009-11-03 | 2012-12-06 | Guy Chamberland | Compositions comprising extracts of boswellia, tea tree, aloe and lavender oil and methods of treating wounds, burns and skin injuries therewith |
| US20120328721A1 (en) * | 2009-11-16 | 2012-12-27 | L | Aloe vera sprout concentrate or extract having superior skin cell growth promotion, antioxidant, and anti-allergy effects |
| US20180085486A1 (en) * | 2015-05-29 | 2018-03-29 | Shirley X. CHEN | Multifunctional composite skin or wound dressing as regenerative skin substitute |
| CN106421511A (en) * | 2016-12-28 | 2017-02-22 | 四川默森药业有限公司 | Aloe antibacterial composition and preparation method thereof |
| CN107007794A (en) * | 2017-06-04 | 2017-08-04 | 重庆华邦医美科技有限公司 | It is a kind of to treat Chinese herbal ointment of scar and preparation method thereof |
| CN112618646A (en) * | 2020-12-30 | 2021-04-09 | 王水龙 | Traditional Chinese medicine composition and traditional Chinese medicine oil for treating burns and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN116099029B (en) | 2025-05-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104758977B (en) | A kind of alginate dressing for treating bedsore and preparation method thereof | |
| TWI445555B (en) | Dressing material containing active constituents of Centella asiatica and application thereof | |
| CN101920042B (en) | Liquid bandage and preparation method | |
| CN103933603B (en) | Human epidermal growth bio-medical glue and preparation method thereof urged by a kind of chitosan | |
| CN104840428B (en) | A kind of hyaluronic acid-chitosan microballoon for being loaded with epidermal growth factor and its preparation method and application | |
| CN101703598A (en) | Chinese medicinal ointment for treating burn or sore and ulcer and preparation method thereof | |
| CN110755675A (en) | Composite biological paste capable of rapidly stopping bleeding and preparation method and application thereof | |
| KR20180060542A (en) | Wound dressing with chitosan hydrogel and pdrn and a dressing therefor | |
| CN103263525A (en) | Gynecological cleaning fluid and preparation method thereof | |
| CN112675354A (en) | Multifunctional rhizoma bletillae medical material and preparation method and application thereof | |
| CN114504567B (en) | Dragon blood liquid adhesive bandage and preparation method thereof | |
| CN109700998B (en) | Compound skin injury regeneration repairing agent and preparation method thereof | |
| KR101971439B1 (en) | Process for producing water-soluble algae film and uses thereof | |
| CN115501385A (en) | Wound film-forming dressing for promoting wound healing and preparation method thereof | |
| WO2017030388A1 (en) | Composition for treating skin wounds | |
| CN116099029A (en) | A kind of disposable postoperative dressing plant concentrated film and its preparation method | |
| CN114949329B (en) | Preparation method of surface modified silk fibroin-aloin double-layer fiber membrane | |
| CN105395527B (en) | A kind of marine organisms shield hinders the preparation method of spray-filming agent | |
| CN102755414A (en) | Traditional Chinese medicine ointment for trauma wound and preparation method thereof | |
| CN113262264A (en) | A Chinese medicinal composition for relieving pain and promoting granulation, and its preparation method | |
| CN112336805A (en) | Scald oil and preparation method thereof | |
| CN120227327B (en) | Cream for promoting healing of oral mucosal skin | |
| LU501050B1 (en) | Chinese medicinal ointment for treating animal trauma and preparation method thereof | |
| CN117959479B (en) | Preparation method of three-dimensional traditional Chinese medicine dressing for treating pressure sores and three-dimensional traditional Chinese medicine dressing prepared by preparation method | |
| CN119174839B (en) | Skin repair liquid dressing and preparation method and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |